BloodFlow logo

BloodFlow

BloodFlow uses AI to interpret blood test results within existing clinical systems.

ShareLink copied

The record

Vertical
Clinical AI & Documentation
Sub-segment
Blood test interpretation
Product type
Platform software
Stage
Seed
Headquarters
Portugal
Region
Europe
Founded
2024
July 2025 seed round
€1.2 million
. Source

What they do

Founded in October 2024 and incubated at Unicorn Factory Lisboa, BloodFlow is led by founder and CEO Tiago Costa. ECO reports that the company integrates blood test interpretation into existing clinical systems through an API. Its official site describes it as “the invisible layer of clinical intelligence embedded in every EMR”. In July 2025, ECO reported a €1.2 million seed round led by 3xP Global through its Health Innovation Fund. Startup Portugal listed a BloodFlow pitch on the Portugal Stand at Web Summit Lisbon on 10 November 2026.

Investors

  • 3xP Global

Sources

  1. ECO funding report
  2. Startup Portugal booklet
  3. The HealthTech Signal: Web Summit Lisbon 2026 preview

Is this your company? Feature it